Virtus ETF Advisers’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,686
| Closed | -$67.8K | – | 490 |
|
|
2024
Q4 | $67.8K | Sell |
1,686
-954
| -36% | -$38.4K | 0.03% | 400 |
|
|
2024
Q3 | $125K | Buy |
2,640
+44
| +2% | +$2.08K | 0.06% | 346 |
|
|
2024
Q2 | $77.5K | Sell |
2,596
-811
| -24% | -$24.2K | 0.04% | 418 |
|
|
2024
Q1 | $137K | Sell |
3,407
-231
| -6% | -$9.29K | 0.07% | 337 |
|
|
2023
Q4 | $92.6K | Sell |
3,638
-199
| -5% | -$5.07K | 0.06% | 396 |
|
|
2023
Q3 | $53.3K | Sell |
3,837
-378
| -9% | -$5.25K | 0.03% | 411 |
|
|
2023
Q2 | $96.9K | Buy |
4,215
+796
| +23% | +$18.3K | 0.06% | 398 |
|
|
2023
Q1 | $101K | Sell |
3,419
-1,310
| -28% | -$38.8K | 0.06% | 335 |
|
|
2022
Q4 | $118K | Sell |
4,729
-2,493
| -35% | -$62.2K | 0.06% | 422 |
|
|
2022
Q3 | $157K | Buy |
7,222
+51
| +0.7% | +$1.11K | 0.06% | 346 |
|
|
2022
Q2 | $141K | Buy |
7,171
+4,273
| +147% | +$84K | 0.05% | 328 |
|
|
2022
Q1 | $123K | Sell |
2,898
-173
| -6% | -$7.34K | 0.06% | 260 |
|
|
2021
Q4 | $195K | Sell |
3,071
-1,134
| -27% | -$72K | 0.07% | 216 |
|
|
2021
Q3 | $247K | Sell |
4,205
-216
| -5% | -$12.7K | 0.11% | 221 |
|
|
2021
Q2 | $214K | Buy |
+4,421
| New | +$214K | 0.09% | 294 |
|